Correction
Published on 12 Jun 2025
Corrigendum: Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1630885
- 194 views
Type at least 3 characters
1,855 articles
Case Report
Published on 12 Jun 2025
Management of multiple primary prostate malignant tumors: case report of synchronous prostatic adenocarcinoma and lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1583504
- 191 views
Original Research
Published on 10 Jun 2025
Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1580370
- 461 views
Original Research
Published on 10 Jun 2025
Follicular dendritic cell sarcoma: a great mimicker with unpredictable clinical course—experience from a tertiary care cancer center in India
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1544803
- 436 views
Case Report
Accepted on 09 Jun 2025
"Sequential lymphomas: may HLA system play a role in this uncommon phenomenon?"
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586454
Review
Published on 09 Jun 2025
Platelets as a potential new immune coordinator in T cell-mediated aplastic anemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1568169
- 619 views
Original Research
Published on 09 Jun 2025
Low-dose ATG/PTCy for graft-versus-host disease prevention in haploidentical transplantation: a single-center experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1569149
- 548 views
Correction
Accepted on 06 Jun 2025
Correction: Efficacy and Safety of Pegylated Interferon in the Treatment of JAK2 V617F -Positive Polycythemia Vera with a Dose De-escalation Strategy: A Single-Center Retrospective Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1641150
- 136 views
Case Report
Published on 06 Jun 2025
Successful treatment with carfilzomib and dexamethasone for relapsed/refractory POEMS syndrome: a case report and review of literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1570981
- 659 views
Editorial
Published on 06 Jun 2025
Editorial: Health-related quality of life among Hodgkin lymphoma survivors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1625160
- 403 views
Review
Accepted on 05 Jun 2025
Cancer associated fibroblasts in tumors: focusing on solid tumors and hematological malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1596947
- 141 views
Review
Accepted on 03 Jun 2025
Latest Research Progress on Amino Acid Metabolism in Hematological Malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1526097
- 212 views
Original Research
Accepted on 03 Jun 2025
Subcutaneous Administration of Isatuximab in Patients With Multiple Myeloma by an On-Body Delivery System: Results of a Nurse Survey
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1547108
- 141 views
Case Report
Published on 03 Jun 2025
Case Report: Epididymal NK/T-cell lymphoma and adrenal diffuse large B-cell lymphoma are misdiagnosed as tuberculosis: two case reports and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1529049
- 495 views
Case Report
Published on 03 Jun 2025
Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1585088
- 584 views
Original Research
Accepted on 02 Jun 2025
Patient and Physician Treatment Preferences in Relapsed/Refractory Follicular Lymphoma: A Discrete Choice Experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1589722
- 306 views